Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Transl Cancer Res. 2017 Jun;6(3):620–632. doi: 10.21037/tcr.2017.05.19

Table 1.

Heng criteria for determining prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy

Hemoglobin
Corrected calcium
Neutrophil count
Platelet count
Karnofsky performance status
Time interval from renal cell carcinoma diagnosis to systemic therapy